Support our Foundation of Myology project
French clinicians have examined the links between autoimmune myasthenia gravis and medications that are traditionally contraindicated (either formally or relatively) for this condition: The National Health Data System (SNDS) was used to conduct a study tracking potential complications associated with…
American doctors have examined the potential risks of over-the-counter herbal products due to their impact on the immune systems of patients with autoimmune conditions such as dermatomyositis: their conclusions are based on a literature review that identified fifteen substances proven…
The European Academy of Neurology (EAN), the leading European professional body in neurology, has brought together experts to discuss the diagnostic approach to be adopted in cases of chronic elevation of CPK-type muscle enzymes: this condition is thought to affect…
L’essai de phase III EMBARK avait présenté des résultats non significatifs contre placebo pour le critère principal à un an, ce qui avait valu un avis défavorable de l’Agence européenne du médicament (EMA) à la commercialisation de l’Elevidys dans la dystrophie musculaire de Duchenne (DMD).…
The disclosure of a diagnosis is a pivotal event in a patient’s care pathway and has been the subject of extensive research across various medical fields, particularly in oncology and psychiatry. However, the specific characteristics of the diagnostic disclosure in…
A retrospective study describes eight pregnancies in six women with severe SMA, who were all wheelchair-dependent, including one case of type I SMA. The three women who were receiving noninvasive ventilation (NIV) at home prior to their pregnancies experienced a…
Around twenty international experts on SMA gathered at a workshop organised by the European Neuromuscular Centre (ENMC) to review the neurodevelopmental disorders observed in a number of children with SMA type I who are receiving or have received innovative therapy:…
Researchers consulted the SMArtCARE registry, which focuses on SMA in Germany, Austria and Switzerland, in the context of innovative therapies available since 2017: data from 2,140 SMA patients listed in the registry were analysed, 60% of them received treatment with…
Chinese clinicians report the case of a 73-year-old patient diagnosed with Lambert-Eaton myasthenic syndrome (LEMS) who underwent treatment with a latest-generation immunosuppressant: the patient met all the criteria necessary to confirm the diagnosis of LEMS, including the onset of motor…
The ENTRY-DM doctoral network (Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy) officially launched in March 2025, and the 14 international doctoral students recruited began their thesis projects in autumn 2025. In this context, the network’s first global meeting,…
The Winter Olympic Games offer a timely reminder of a fundamental truth: muscle is not only responsible for athletic prowess and sporting performance, it is, above all, a major public health issue. By interacting with many organs, muscles are central to our overall good health. To strengthen public awareness and promote the integration of muscle health into public…
Bruno Cadot, researcher at the Center of Research in Myology and head of the MyoImage technology platform, oversaw the acquisition of a latest-generation Nikon AXR-NSPARC confocal microscope equipped with an N-STORM super-resolution module*. This new high-performance device adds to the platform’s…
While nusinersen is currently administered at a dose of 12 mg intrathecally, a new treatment device with higher doses (50 mg and 28 mg) has just been authorised by the European Commission. This follows the results of the DEVOTE trial,…
While there is still no consensus on the treatment of ocular myasthenia gravis, an Italian team conducted a retrospective study of 174 patients initially diagnosed with an ocular form of myasthenia gravis: 112 underwent thymectomy at the ocular stage of…
On Tuesday 17 June, we laid the corner stone for our future Foundation of Myology, the first foundation worldwide dedicated to muscle research, in the presence of Jérome Coumet, Mayor of the 13th arrondissement of Paris and Chairman of SEMAPA,…
The Institute welcomed its first class of medical students for an introduction to research in the field of myology in April 2023. This week of training, which is part of the medical curriculum at Sorbonne University, was organised by Guillaume…